Pharmaceuticals News

Vancouver, British Columbia--(Newsfile Corp. - October 3, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced that it has expanded its patent portfolio through the filing of...
Technology, Pharmaceuticals, Health
2022-10-03 5:30 PM EDT | Lobe Sciences Ltd.

Calgary, Alberta--(Newsfile Corp. - October 3, 2022) - Further to our news release of September 1, 2022, NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (formerly, EnerSpar Corp. or "EnerSpar") (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, is announcing today...
Pharmaceuticals
2022-10-03 5:00 PM EDT | NurExone Biologic Inc.

VINIA® sales orders reached a record high of USD 1.71M representing 145% growth compared to Q3 2021 and 81% growth compared to Q2 2022Q3 Sales in the US delivered 3X the sales of Q2 2022 and crossed the USD 1 Million mark Strong sales momentum and increase in subscribers support...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Cultivator
2022-10-03 7:30 AM EDT | BioHarvest Sciences Inc.

Toronto, Ontario--(Newsfile Corp. - October 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that, further to the Company's news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the "Supplemental...
Pharmaceuticals, Cannabis, Health
2022-10-03 7:00 AM EDT | VIVO Cannabis Inc.

San Diego, California--(Newsfile Corp. - September 30, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet needs, reports that its stockholders voted in favor of all proposals presented at its special...
Biotechnology, Pharmaceuticals, Cannabis, Health
2022-09-30 3:24 PM EDT | Skye Bioscience, Inc.

All resolutions submitted for approval were passed by shareholdersVancouver, British Columbia--(Newsfile Corp. - September 29, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announces the results of its Annual General Meeting of...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-09-29 8:30 AM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies including Antibody Drug Conjugate ("ADC"), is pleased to announce that...
Biotechnology, Pharmaceuticals, Health
2022-09-29 3:15 AM EDT | Defence Therapeutics Inc.

Toronto, Ontario--(Newsfile Corp. - September 28, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that its board of directors (the "Board") has appointed Philip Lambert, Ph.D.,...
Biotechnology, Pharmaceuticals, Health
2022-09-28 7:30 AM EDT | Satellos Bioscience Inc.

Calgary, Alberta--(Newsfile Corp. - September 27, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Ernst von Schwarz, MD, PhD, FESC, FACC, FSCAI to its Scientific Advisory Board.Dr. von Schwarz is a US based world renowned, triple...
Biotechnology, Pharmaceuticals, Health
2022-09-27 9:00 AM EDT | Hemostemix Inc.

Jackson Center, Pennsylvania--(Newsfile Corp. - September 27, 2022) - Halberd Corporation (OTC Pink: HALB) entered into a strategic alliance with AI Longevity, Inc. and Stem of Hope to form a strategic alliance as a wholly owned subsidiary of Halberd Corporation named "ExtendalifeTM". The mission will be to develop treatments intended...
Biotechnology, Pharmaceuticals, Health
2022-09-27 8:00 AM EDT | Halberd Corp.

Salt Lake City, Utah--(Newsfile Corp. - September 26, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced that its stockholders authorized a reverse stock split of the Company's common stock. Following the annual stockholder meeting, the board of directors approved a reverse stock split of one share...
Biotechnology, Pharmaceuticals
2022-09-26 6:45 AM EDT | Kiora Pharmaceuticals, Inc.

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2022) -  Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced it has incorporated Lobe Sciences Australia Pty Ltd., a 100% owned...
Technology, Pharmaceuticals, Health
2022-09-23 8:00 AM EDT | Lobe Sciences Ltd.

Bill Radvak, Co-founder and Executive Chairman of the Board, appointed interim Chief Executive Officer Dr. Adam Rogers, member of the Board of Directors, appointed interim President Paul Brennan to step down as President & Chief Executive Officer and member of the Board of Directors; will serve as a strategic advisor...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-09-22 7:21 PM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2022) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that pursuant to the Company's existing Stock Option Plan, a total of 1,000,000 incentive stock options have been granted to a consultant of the Company. These stock options are exercisable at...
Technology, Biotechnology, Pharmaceuticals, Alternative Energy
2022-09-22 2:51 PM EDT | Solarvest BioEnergy Inc.

Miami, Florida--(Newsfile Corp. - September 22, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is thrilled to announce the special screening of the short documentary film "The World on Drugs," produced by Microdose and directed by Connor Haslam, CEO of Microdose Psychedelic Insights at Wonderland. Wonderland,...
Pharmaceuticals, Cannabis, Psychedelics, Cannabis Manufacturer
2022-09-22 9:00 AM EDT | Microdose Psychedelic Insights

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2022) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), a federally regulated manufacturer and distributor of cannabis extracts including vapes, oils, and softgel capsules, is excited to announce the launch of its new brand High Plains.High Plains...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2022-09-22 8:45 AM EDT | Nextleaf Solutions Ltd.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical tech company focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, is pleased to provide the following operational update on...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2022-09-21 7:05 AM EDT | Innocan Pharma Corporation

Vancouver, British Columbia--(Newsfile Corp. - September 21, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report that Defence's novel vaccine candidate triggers a potent...
Biotechnology, Pharmaceuticals, Health
2022-09-21 3:15 AM EDT | Defence Therapeutics Inc.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 20, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced positive clinical data at the Transcatheter Cardiovascular Therapeutics Conference ("TCT") held September 16-19 in Boston.Prof. Shmuel Banai, MD, Neovasc Medical Director and Head of Interventional Cardiology at...
Pharmaceuticals, Health
2022-09-20 9:05 AM EDT | Neovasc Inc.